Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study.
Annick MoensC Janneke van der WoudeMette JulsgaardEvelien HumbletJuliette SheridanDaniel C BaumgartCyrielle Gilletta De Saint-JosephStéphane NanceyJean-François RahierPeter BossuytAnneline CremerSophie DewitCarl ErikssonFrank HoentjenThomas KrauseEdouard LouisElisabeth MackenZoran MilenkovicJochen NijsAnnelies PosenAnneleen Van HootegemWouter Van MoerkerckeSéverine VermeireAriella Bar-Gil ShitritMarc FerrantePublished in: Alimentary pharmacology & therapeutics (2019)
No new safety signal was detected in VDZE pregnancies although larger, prospective studies are required for confirmation.